The Valley Desk

ArticleJAMA network openPublished

Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
JAMA network open
Published
Subject terms
Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Retrospective Studies; Cross-Sectional Studies; Aged; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized; Drug-Related Side Effects and Adverse Reactions
PubMed ID
42166160
PubMed Central ID
PMC13195479
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal